Truist raised the firm’s price target on Alteryx to $45 from $40 and keeps a Buy rating on the shares. The analyst cites the company’s “strong” Q3 earnings beat driven by execution improvements starting to take hold. Truist adds that heading into its biggest renewal quarter, the performance gives the firm incremental confidence in its ability to execute against an uncertain macro backdrop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AYX: